TrialClinical and molecular hepatology2021

Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial.

Do Seon Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.